These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 37996192)

  • 1. Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having.
    Sharon E; Othus M; Quandt ZE
    Cancer; 2023 Sep; 129(18):2769-2770. PubMed ID: 37439269
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Vural Keskinler M; Telci Caklili O; Oguz A
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894. PubMed ID: 37996194
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ceriello A; Prattichizzo F; Berra CC; Caballero AE
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894-895. PubMed ID: 37996193
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial - Authors' reply.
    Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):895-896. PubMed ID: 37996195
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive glucose lowering arm of diabetes trial is stopped after excess deaths.
    Mayor S
    BMJ; 2008 Feb; 336(7641):407. PubMed ID: 18292149
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Real-World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment.
    Abrahami D; Pradhan R; Yin H; Honig P; Baumfeld Andre E; Azoulay L
    Clin Pharmacol Ther; 2021 Feb; 109(2):452-461. PubMed ID: 32767673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ahmed A; Anker SD; Butler J; Bakris GL; Bhatt DL; Fonarow GC; Packer M
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):892-894. PubMed ID: 37996192
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide for the treatment of type 2 diabetes.
    Shyangdan D; Cummins E; Royle P; Waugh N
    Health Technol Assess; 2011 May; 15 Suppl 1():77-86. PubMed ID: 21609656
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.